Quick Answer
Dare Bioscience, Inc. reported R&D Expense of $5.52 million for fiscal year 2025.
Dare Bioscience, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $5.52M | -61.4% |
| 2024 | $14.31M | -33.6% |
| 2023 | $21.54M | -28.3% |
| 2022 | $30.04M | -1.9% |
| 2021 | $30.62M | +47.4% |
| 2020 | $20.77M | +143.0% |
| 2019 | $8.55M | +33.2% |
| 2018 | $6.41M | +551.3% |
| 2017 | $984.7K | +1255.2% |
| 2016 | $72.7K | -99.7% |
| 2015 | $25.95M | +120.4% |
| 2014 | $11.77M | +21.4% |
| 2013 | $9.70M | -38.6% |
| 2012 | $15.81M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.18M | -56.2% | -17.7% |
| June 30, 2025 | $1.43M | -71.0% | -37.8% |
| March 31, 2025 | $2.30M | -31.5% | -14.3% |
| September 30, 2024 | $2.68M | -59.8% | -45.6% |
| June 30, 2024 | $4.93M | -18.4% | +47.1% |
| March 31, 2024 | $3.35M | -33.2% | -49.8% |
| September 30, 2023 | $6.67M | +49.6% | +10.4% |
| June 30, 2023 | $6.04M | -11.1% | +20.4% |
- Dare Bioscience, Inc. showed a decrease of -61.4% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, Dare Bioscience, Inc.’s r&d expense has declined by 65.1% (from $15.81 million to $5.52 million).
- The most recent figure is from Dare Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: